Story
Update:
All done. Wow. Pain ++++. Thank you to everyone that has supported us so far …. v v grateful
Philip: “As a Consultant Urological Surgeon (The Royal Berkshire Hospital & GenesisCare UK) with a specialist clinical interest in Prostate Cancer & Bladder Cancer, I spend most of my week performing stressful and complex operations."
“I’ve also seen first-hand how important the work of organisations such as Prostate Cancer Research UK is in working tirelessly with world-leading scientists to deliver vital breakthrough medicines and treatments for those with prostate cancer.
Graeme: "My wife is a busy local GP and regularly refers men with prostate problems to surgeons such as Philip. And as a man in my mid 40s I realise I am getting to an age where the risks of prostate cancer become higher and that it's probably not long until I have a doctor for their advice"
Philip: “Due to the nature of my job exercise is important to me for both my physical and mental health, and what I witness working in this field has been a major motivator to channel that into fundraising attempts. Not only that, but as we know, exercise is proven to help reduce your risk of prostate cancer!"
Graeme: "I have always enjoyed being outside and am a very keen cyclist, and regularly cover over 5000miles a year with my commute to and from work. I find it's a great way to wake up before work and
gives me time to process my work at the end of the day. Philip has a habit of roping me in for his madcap exercise ideas - he previously asked me to join him raising money for a surgical robot at The Royal Berkshire Hospital, which is still used today to treat patients with Prostate Cancer in Berkshire."
Philip: “Having completed the London Marathon in 2019 and the long-distance two-mile Swim the Serpentine in 2021, I am excited to complete the RideLondon 100 in Spring 2022. The aim is to raise £10,000 for Prostate Cancer Research UK – and every penny of support will make a huge difference in raising awareness around the issue and help develop potentially lifesaving treatments, which will improve the outlook for patients and their families.”